Qiagen Inks HPV Screening Deal with China's KingMed Diagnostics

Mar 08, 2012

NEW YORK (GenomeWeb News) – Qiagen has signed a co-marketing deal in China with KingMed Diagnostics aimed at expanding access to its digene HPV test.

KingMed is China's largest independent laboratory network, according to Qiagen, and under the agreement will serve as a centralized lab. This will allow smaller hospitals and those in less-populated areas to offer the HPV test and send samples to KingMed for processing and analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

O Canad[ian Science]!

As the Canadian election season heats up, neither major party has really paid much attention to science, according to Nature News.

Brexit Woes Affecting Science Funding

BBC News says the uncertainty over Brexit is affecting science funding in the UK.

"Gayness" App Raises Ire Among Scientists

A new app purports to tell users "how gay" they are by looking at their DNA, but experts tell Futurism that the app is bunk.

Nature Papers Examine the Use of Human and Great Ape Cerebral Organoids, and More

In Nature this week: human and great ape cerebral organoids reveal aspects of brain development unique to humans, and more.

Featured White Papers

BlueBee Data Security & Compliance

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu